News

Find News

Filter articles

Showing 3031 to 3040 of 3112 results

IPAB throws out Indian Vega trademarks

India02-08-2013

The Intellectual Property Appellate Board in Chennai has cancelled two trademarks associated with versions of Viagra.

UK Appeals Court upholds Teva’s Copaxone patent

UK01-08-2013Legal developments

The Court of Appeal for England and Wales has upheld the Patent Court’s decision that Teva Pharmaceutical Industries’ UK patent 762,888, relating to the multiple sclerosis drug Copaxone, is valid.

US court rules Teva patent invalid

30-07-2013

A US court has ruled that an Israeli company’s patent for a multiple sclerosis (MS) drug is invalid, paving the way for rivals to market a generic version.

Novozymes loses appeal in DuPont patent war

US26-07-2013

A US court has upheld a decision ruling that a continuation patent filed by a bio-tech company is invalid.

FTC welcomes Supreme Court 'pay-for-delay' ruling

US25-07-2013

The chair of the FTC has said it will continue to challenge pay-for-delay court settlements in the pharmaceutical industry and has hailed a Supreme Court ruling as a victory for consumers.

Ability to settle cases influences generic patent challenges, study finds

US25-07-2013

A white paper suggests that patent case settlements between originator pharmaceutical companies and their generic competitors may be beneficial to drug consumers.

USPTO announces departure of general counsel

US24-07-2013

The chief legal officer at the United States Patent and Trademark Office has announced he will be leaving.

Leahy demands Myriad “march-in rights”

US19-07-2013

Senator Patrick Leahy has urged the US National Institutes of Health to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer.

Ipsen announces acquisition of research partner Syntaxin

France, US18-07-2013

On July 15, French pharmaceutical company Ipsen announced it has closed the acquisition of life sciences company and research partner Syntaxin.

US appeals court refuses Arzerra rehearing

US17-07-2013

Biotechnology company Genmab A/S announced on July 15 that the US Court of Appeals for the Federal Circuit has refused a request to rehear a case related to its Arzerra product.

Showing 3031 to 3040 of 3112 results

LSIPR